Newbridge Financial Services Group, Inc. Recursion Pharmaceuticals, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $275 Million
- Q3 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 2,460 shares of RXRX stock, worth $18,622. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,460
Previous 2,340
5.13%
Holding current value
$18,622
Previous $17,000
5.88%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding RXRX
# of Institutions
287Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$248 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$191 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$184 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$131 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$116 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.37B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...